Workstream Type: Policy Solutions

  • Comparing Factors that Influence Pharmaceutical Pricing and Access in the US and five other Countries

  • Production Plus Profit Pricing (P-quad) FAQ

  • We can’t tackle the pandemic without figuring out which Covid-19 vaccines work the best

  • The Drugs at the Heart of Our Pricing Crisis

  • Biosimilars: Market Changes do not equal policy success

  • Curbing Biologic Drug Spending with P-quad

  • Modeling P-quad

  • Research on the current state of US drug pricing and its effects

  • Develop solutions to align drug prices with value

  • Who Is Sowing Seeds of Confusion About The QALY?